Table 3.
Treatment history
| Characteristic | Study participant | |
|---|---|---|
| Number, total = 146 | % | |
| Time off antihypertensives | ||
| 1 week | 50 | 34 |
| 1 to <2 weeks | 42 | 29 |
| 2 to ≤4 weeks | 17 | 12 |
| 1 month | 13 | 9 |
| >1 month | 22 | 15 |
| No record | 2 | 1 |
| Single drug antihypertensives | ||
| Duiretic | 2 | 6 |
| Calcium channel blocker | 13 | 38 |
| Beta blocker | 8 | 24 |
| ACEI/ARBs | 9 | 26 |
| Others | 1 | 3 |
| No record | 1 | 3 |
| Combination drug antihypertensive | ||
| Duiretic and Calcium Ch. | 13 | 12 |
| Duiretic and ACEI/ARB | 5 | 4 |
| Calcium Ch and beta blocker | 10 | 9 |
| Calcium Ch. and ACEI/ARB | 19 | 17 |
| Beta block + ACEI/ARBs | 6 | 5 |
| Duiretic + calcium ch + ACEI/ARB | 27 | 24 |
| Others | 27 | 24 |